Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 241 institutions that hold shares in the stock, with a total of 79.5 Million shares, which have been reported (via 13F filing form) to have a value of $4.26 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
6,287,655
shares
|
$337 Million
0.01% of portfolio
|
Q3 2024
Added 39.28%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,230,371
shares
|
$334 Million
0.01% of portfolio
|
Q2 2024
Added 14.61%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
5,885,248
shares
|
$315 Million
2.95% of portfolio
|
Q3 2024
Reduced 3.71%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
4,944,757
shares
|
$265 Million
0.03% of portfolio
|
Q3 2024
Added 12.22%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,459,691
shares
|
$239 Million
0.04% of portfolio
|
Q3 2024
Reduced 3.48%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
4,288,120
shares
|
$230 Million
9.5% of portfolio
|
Q3 2024
Added 3.19%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,838,484
shares
|
$152 Million
0.01% of portfolio
|
Q3 2024
Added 0.91%
|
|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
2,793,614
shares
|
$150 Million
0.09% of portfolio
|
Q3 2024
Added 0.48%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,516,686
shares
|
$135 Million
4.63% of portfolio
|
Q3 2024
Added 0.13%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
2,429,450
shares
|
$130 Million
0.07% of portfolio
|
Q3 2024
Reduced 1.07%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
2,300,643
shares
|
$123 Million
0.32% of portfolio
|
Q3 2024
Reduced 17.27%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,848,133
shares
|
$99.1 Million
0.01% of portfolio
|
Q3 2024
Added 10.11%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 27, 2024 Q3 2024 |
1,390,110
shares
|
$74.5 Million
0.02% of portfolio
|
Q3 2024
Added 61.37%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
1,309,652
shares
|
$70.2 Million
3.35% of portfolio
|
Q3 2024
New holding
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,162,000
shares
|
$62.3 Million
0.3% of portfolio
|
Q3 2024
Added 133.8%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,100,000
shares
|
$59 Million
3.94% of portfolio
|
Q3 2024
Reduced 18.52%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,068,532
shares
|
$57.3 Million
0.03% of portfolio
|
Q3 2024
Reduced 20.69%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,050,055
shares
|
$56.3 Million
1.26% of portfolio
|
Q3 2024
Reduced 18.02%
|
|
|
Novo Holdings
Hellerup, G7 |
Oct 24, 2024 Q3 2024 |
1,000,000
shares
|
$53.6 Million
3.57% of portfolio
|
Q2 2024
Reduced 8.98%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Nov 14, 2024 Q3 2024 |
943,611
shares
|
$50.6 Million
4.2% of portfolio
|
Q3 2024
Reduced 21.4%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
908,149
shares
|
$48.7 Million
0.05% of portfolio
|
Q3 2024
Added 201.84%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Nov 14, 2024 Q3 2024 |
834,912
shares
|
$44.8 Million
0.79% of portfolio
|
Q3 2024
Added 103.47%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
787,028
shares
|
$42.2 Million
0.01% of portfolio
|
Q3 2024
Added 21.23%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Dec 13, 2024 Q3 2024 |
746,118
shares
|
$40 Million
0.12% of portfolio
|
Q3 2024
Reduced 15.97%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
735,088
shares
|
$39.4 Million
0.66% of portfolio
|
Q2 2024
Reduced 30.63%
|